ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells

Tumor Biology

Volumn 35, Issue 9, 2014, Pages 9263-9268

  Fu, Lin ^a   Liu, Nan ^a   Han, Yong ^a   Xie, Chengyao ^a   Li, Qingchang ^a   Wang, Enhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Chemoresistance; Invasion; Migration; Proliferation

Indexed keywords

ADAM10 ENDOPEPTIDASE; CASPASE 3; CISPLATIN; SMALL INTERFERING RNA; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; MEMBRANE PROTEIN; SECRETASE;

ADULT; ADVANCED CANCER; AGED; APOPTOSIS; ARTICLE; BIOLOGICAL FUNCTIONS; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER GRADING; CANCER RESISTANCE; CANCER STAGING; CANCER TISSUE; CELL ASSAY; CELL GROWTH; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN DEPLETION; PROTEIN EXPRESSION; BIOSYNTHESIS; BLADDER TUMOR; CELL MOTION; DRUG EFFECTS; DRUG RESISTANCE; FLOW CYTOMETRY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

ADAM PROTEINS; AGED; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RNA INTERFERENCE; URINARY BLADDER NEOPLASMS;

EID: 84919860326     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2201-9     Document Type: Article

References (19)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62(1):10–29.
2. Han B, Luan L, Xu Z, Wu B. Expression and biological roles of SATB1 in human bladder cancer. Tumour Biol. 2013;34(5):2943–9.
3. Wang C, Wang W, Wang J, Zhan H, Jiang L, Yan R, et al. Apoptin induces apoptosis in nude mice allograft model of human bladder cancer by altering multiple bladder tumor-associated gene expression profiles. Tumour Biol. 2013;34(3):1667–78.
4. Yan L, Yan K, Kun W, Xu L, Ma Q, Tang Y, et al. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase. Tumour Biol. 2013;34(1):215–21.
5. Sanchez-Carbayo M. Hypermethylation in bladder cancer: biological pathways and translational applications. Tumour Biol. 2012;33(2):347–61.
6. Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med. 2008;29(5):258–89.
7. Rocks N, Paulissen G, El Hour M, Quesada F, Crahay C, Gueders M, et al. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie. 2008;90(2):369–79.
8. Duffy MJ, McKiernan E, O’Donovan N, McGowan PM. Role of ADAMs in cancer formation and progression. Clin Cancer Res. 2009;15(4):1140–4.
9. Saftig P, Reiss K. The “A disintegrin and metalloproteasesˮ ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur J Cell Biol. 2011;90(6–7):527–35.
10. Gaida MM, Haag N, Gunther F, Tschaharganeh DF, Schirmacher P, Friess H, et al. Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma. Int J Mol Med. 2010;26(2):281–8.
11. Ko SY, Lin SC, Wong YK, Liu CJ, Chang KW, Liu TY. Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Lett. 2007;245(1–2):33–43.
12. Lee SB, Schramme A, Doberstein K, Dummer R, Abdel-Bakky MS, Keller S, et al. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. J Invest Dermatol. 2010;130(3):763–73.
13. Guo J, He L, Yuan P, Wang P, Lu Y, Tong F, et al. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway. Oncol Rep. 2012;28(5):1709–18.
14. Lendeckel U, Kohl J, Arndt M, Carl-McGrath S, Donat H, Rocken C. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines. J Cancer Res Clin Oncol. 2005;131(1):41–8.
15. Yang CL, Jiang FQ, Xu F, Jiang GX. ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma. Tumour Biol. 2012;33(5):1535–41.
16. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, et al. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol. 2005;168(4):633–42.
17. Xu Q, Liu X, Chen W, Zhang Z. Inhibiting adenoid cystic carcinoma cells growth and metastasis by blocking the expression of ADAM 10 using RNA interference. J Transl Med. 2010;8:136.
18. D’Amelio M, Cavallucci V, and Cecconi F, Neuronal caspase-3 signaling: not only cell death. Cell Death Differ. 17(7): p. 1104-14.
19. Yan F, Liu Y, Wang W. Matrine inhibited the growth of rat osteosarcoma UMR-108 cells by inducing apoptosis in a mitochondrial-caspase-dependent pathway. Tumour Biol. 2013;34(4):2135–40.